The Mix Talent team had a wonderful time volunteering with the YWCA Columbus last Friday at a giveaway market for their Women's Residency Program! This is a fantastic program that served over 100 women in 2023 alone, providing access to wellness and recovery support, community resources, workshops, social activities, medical help, and more. Learn more here - https://lnkd.in/g_AwwCDh #volunteer #care #communityservice #ywca
Mix Talent
Staffing and Recruiting
Columbus, Ohio 41,642 followers
Culture is built by people. And runs on talent.
About us
Mix Talent was built to support the near-term goals and long-term success of pharma, biotech, HealthTech, and gene therapy organizations. We recognize the power of your company culture, and we specialize in identifying, recruiting, assessing, selecting, and developing talent that fits and fortifies that culture. As our name demonstrates, we believe it’s essential to find that right mix of skills, experience, personality, and personal motivation to ensure long-term success. And to do that, you need to do it differently. Our unique mix of knowledge, technology, and instinct has helped clients go beyond just hiring headcount to truly creating dynamic organizations. The secret’s in the mix.
- Website
-
https://www.mix-talent.com
External link for Mix Talent
- Industry
- Staffing and Recruiting
- Company size
- 51-200 employees
- Headquarters
- Columbus, Ohio
- Type
- Partnership
- Founded
- 2018
Locations
-
Primary
1349 W Lane Ave
1010
Columbus, Ohio 43221, US
Employees at Mix Talent
Updates
-
Great news from Bicara Therapeutics and Zenas BioPharma as both file for IPOs!
-
When hiring #lifesciences talent, look beyond the right experience – find candidates with the right motivation, the right competencies, and the right values that align with your culture. That's how you find people that make a true difference in your organization. Ready to find your mix? Reach out to Mix today. #getinthemix #mixtalent #findyourmix
-
If you’re looking to elevate your contract teams and put talent at the center of your organization’s success 🎯 you need to check out our new ebook, "Why Contract Teams Fail: How to avoid common pitfalls with a talent-centered approach." In it, we break down our best practices for contract team success, including: • How to select the right talent • The importance of aligning talent with mission and values • Strategies for optimizing performance Download your copy today: https://lnkd.in/eTgGzXq2
-
-
A big congratulations to Visiox Pharmaceuticals for their merger with Ocuvex Therapeutics! "We have reached significant milestones with our products and Ocuvex is in a great position to take these advancements forward and bring them to market faster and emerge as a future leader in eye care." — Ryan Bleeks, Chief Executive Officer of Visiox
Today, Visiox announces merger with Ocuvex Therapeutics, Inc. that strengthens ophthalmic portfolio and accelerates commercialization. Learn more here https://lnkd.in/emYjnCTr #news #innovation #merger Ryan Bleeks Sanjay Reddy Cynthia Matossian, MD
Visiox Pharmaceuticals, Inc. Announces Transformative Merger with Ocuvex Therpeutics, Inc.
prnewswire.com
-
Survey results are in! 📊 🌴 For most, leaving your work devices at home is the best way to maximize the benefits of vacation, followed by setting clear expectations with your team and removing apps/notifications from your devices. Turns out, it's a lot easier to avoid temptation to check in on projects when your devices aren't within arm's reach – but it's also worth making sure your team understands your intention to #unplug. #mixtalent #summervacation #lifesciences
-
-
Congratulations to Syndax Pharmaceuticals and Incyte for U.S. FDA approval of Niktimvo! “The approval of Niktimvo represents a significant treatment advancement for patients with chronic GVHD who have failed at least two lines of previous therapy,” said Michael A. Metzger, Chief Executive Officer, Syndax. Read the full press release - https://lnkd.in/gjDqy_7v And tune into their live webcast today at 6:00pm ET!
We’re excited to announce a landmark achievement for Syndax and our partners at Incyte. Niktimvo (axatilimab-csfr) is now U.S. FDA-approved! We would like to extend our appreciation to the clinicians, investigators, Syndax and Incyte employees, and patients who made our first-ever approval possible. Learn more by reading our press release and tuning in to our live webcast today at 6:00 p.m. ET: https://lnkd.in/gjDqy_7v
-
-
Mix Talent reposted this
The White House has revealed significantly reduced prices for 10 prescription drugs affected by the first wave of Medicare negotiations mandated by the Inflation Reduction Act.
IRA negotiations slash Medicare prices for Big Pharma blockbusters by up to 79%
fiercepharma.com
-
It's a great time to be in the #lifesciences in Ohio! "Ohio is one of just four states with three or more different geographies leading the life sciences," per an article by Ohio Life Sciences - https://lnkd.in/gV5v_chY We're so grateful for our partnership with OLS and excited to see the continued investments from JP Nauseef and the JobsOhio team. #growth #innovation #ohio #mixtalent
Ohio’s Life Sciences Workforce Recognized in New National Report
Ohio Life Sciences on LinkedIn